Steve Miller - 11 May 2023 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Chief Operating Officer
Signature
/s/ Steve Miller
Issuer symbol
CPRX
Transactions as of
11 May 2023
Net transactions value
+$79,000
Form type
4
Filing time
12 May 2023, 17:00:54 UTC
Previous filing
17 Feb 2023
Next filing
07 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common stock, par value $0.001 per share Options Exercise $79,000 +100,000 +17% $0.7900* 687,457 11 May 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Options Exercise $0 -100,000 -6.2% $0.000000 1,515,334 11 May 2023 Common Stock 100,000 $0.7900 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on June 15, 2016 and previously vested in two annual installments.